|
1
|
Raynaud CM, Sabatier L, Philipot O,
Olaussen KA and Soria JC: Telomere length, telomeric proteins and
genomic instability during the multistep carcinogenic process. Crit
Rev Oncol Hematol. 66:99–117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Djojosubroto MW, Choi YS, Lee HW and
Rudolph KL: Telomeres and telomerase in aging, regeneration and
cancer. Mol Cells. 15:164–175. 2003.PubMed/NCBI
|
|
3
|
Taga S, Osaki T, Ohgami A, Imoto H and
Yasumoto K: Prognostic impact of telomerase activity in non-small
cell lung cancers. Ann Surg. 230:715–720. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hiyama K, Hiyama E, Ishioka S, Yamakido M,
Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in
small-cell and non-small cell lung cancers. J Natl Cancer Inst.
87:895–902. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
6
|
Xia Y, Lin RX, Zheng SJ, Yang Y, Bo XC,
Zhu DY and Wang SQ: Effective siRNA targets screening for human
telomerase reverse transcriptase. World J Gastroenterol.
11:2497–2501. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
The World Health Organization histological
typing of lung tumours. Second edition. Am J Clin Pathol. 77. pp.
123–136. 1982
|
|
8
|
Schleusener JT, Tazelaar HD, Jung SH, Cha
SS, Cera PJ, Myers JL, Creagan ET, Goldberg RM and Marschke RF Jr:
Neuroendocrine differentiation is an independent prognostic factor
in chemotherapy-treated nonsmall cell lung carcinoma. Cancer.
77:1284–1291. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Graziano SL, Tatum AH, Newman NB, Oler A,
Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S and O'Lear S:
The prognostic significance of neuroendocrine markers and
carcinoembryonic antigen in patients with resected stage I and II
non-small cell lung cancer. Cancer Res. 54:2908–2913.
1994.PubMed/NCBI
|
|
10
|
Zaffaroni N, De Polo D, Villa R, Della
Porta C, Collini P, Fabbri A, Pilotti S and Daidone MG:
Differential expression of telomerase activity in neuroendocrine
lung tumours: correlation with gene product immunophenotyping. J
Pathol. 201:127–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kosciolek BA, Kalantidis K, Tabler M and
Rowley PT: Inhibition of telomerase activity in human cancer cells
by RNA interference. Mol Cancer Ther. 2:209–216. 2003.PubMed/NCBI
|
|
12
|
Zhou X and Zhang PH: Stable inhibition of
hTERT gene by siRNA in hepatocarcinoma cells. J Fourth Mi1 Med
Univ. 26:2233–2236. 2005.
|
|
13
|
Reynolds A, Leake D, Boese Q, Scaringe S,
Marshall WS and Khvorova A: Rational siRNA design for RNA
interference. Nat Biotechnol. 22:326–330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ui-Tei K, Naito Y, Takahashi F, Haraguchi
T, Ohki-Hamazaki H, Juni A, Ueda R and Saigo K: Guidelines for the
selection of highly effective siRNA sequences for mammalian and
chick RNA interference. Nucleic Acids Res. 32:936–948. 2004.
View Article : Google Scholar
|
|
15
|
Pham JW, Pellino JL, Lee YS, Carthew RW
and Sontheimer EJ: A Diecr-2- dependent 80s complex cleaves
targeted mRNAs during RNAi in Drosophila. Cell. 117:83–94. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Godfrey A, Anderson J, Papanastasiou A,
Takeuchi Y and Boshoff C: Inhibiting primary effusion lymphoma by
lentiviral vectors encoding short hairpin RNA. Blood.
105:2510–2518. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andersson MG, Haasnoot PC, Xu N, Berenjian
S, Berkhout B and Akusjärvi G: Suppression of RNA interference by
adenovirus virus-associated RNA. J Virol. 79:9556–9565. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Erfle H, Neumann B, Liebel U, Rogers P,
Held M, Walter T, Ellenberg J and Pepperkok R: Reverse transfection
on cell arrays for high content screening microscopy. Nat Protoc.
2:392–399. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He GP, Zhang SZ, Wang YC, Xiao CY, Ma YX,
Xu WM, Ding L, Tao DC, Sun Y and Chen YJ: Time and dose effect of
RNA interference mediated by short hairpin RNA. Progress in
Biochemistry and Biophysics. 32:258–267. 2005.
|
|
20
|
Shammas MA, Koley H, Batchu RB, Bertheau
RC, Protopopov A, Munshi NC and Goyal RK: Telomerase inhibition by
siRNA causes senescence and apoptosis in Barrett’s adenocarcinoma
cells: mechanism and therapeutic potential. Mol Cancer.
4:242005.PubMed/NCBI
|
|
21
|
Collins K and Mitchell JR: Telomerase in
the human organism. Oncogene. 21:564–579. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martinez J, Patkaniowska A, Urlaub H,
Lührmann R and Tuschl T: Single-stranded antisense siRNAs guide
target RNA cleavage in RNAi. Cell. 110:563–574. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Castanotto D, Li HT and Rossi IJ:
Functional siRNA expression form transfected PCR products. RNA.
8:1454–1460. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu N, Gu HJ and Li Q: Effects of
antidiabetic drug metformin on the migration and invasion abilities
of human pulmonary adenocarcinoma A549 cell line in vitro. J Thorac
Dis. 2:76–78. 2010.PubMed/NCBI
|
|
25
|
Shao WL, Wang DY and He JX: The role of
gene expression profiling in early-stage non-small cell lung
cancer. J Thorac Dis. 2:89–99. 2010.PubMed/NCBI
|
